Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Neoplasms 2Stomach Neoplasms 1Precancerous Conditions 1Lung Neoplasms 1Hemoptysis 1HIV Infections 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Bites and Stings 1Anus Neoplasms 1Airway Obstruction 1

Interventions

Oxaliplatin 200Capecitabine 116S 1 (combination) 106Fluorouracil 105Docetaxel 100Cisplatin 88Leucovorin 75Paclitaxel 71Irinotecan 68apatinib 43sintilimab 42Drug Therapy 42Surgical Procedures, Operative 37Hyperthermic Intraperitoneal Chemotherapy 34pembrolizumab 32Radiotherapy 31Trastuzumab 30Gastrectomy 23Nivolumab 22Epirubicin 22Tegafur 21Bevacizumab 21XELOX 20titanium silicide 19camrelizumab 19tislelizumab 17Ramucirumab 17Carboplatin 16Neoadjuvant Therapy 15Endoscopic Mucosal Resection 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Stomach Neoplasms × Argon Plasma Coagulation × Clear all
NCT07161479 2026-02-06

Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)

Samsung Medical Center

Phase NA Recruiting
160 enrolled
GastrointestinalOther neoplasm

Precancerous Conditions, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡